Please assess the completion status of the following clinical trial:

Trial Title: Intradialytic Parenteral Nutrition in Hemodialysis Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* hemodialysis therapy more than 6 months~* three times per week hemodialysis~* albumin \< 35 g/l~* prealbumin \< 250 mg/l~* phase angle \< 4,5°~* SGA score grade B or C~* informed consent~Exclusion Criteria:~* inadequate dialysis (Kt/V \< 1,2)~* chemotherapy or radiotherapy~* cardiac pacemaker~* acute bacterial infection~* acute immunological disease~* cancer disease~* severe hepatic insufficiency~* interferon therapy~* HIV disease~* severe diabetes mellitus

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Intradialytic parenteral nutrition (Type: EXPERIMENTAL): Individually compounded intradialytic parenteral nutrition (IDPN) including glucose, amino acids, lipids, L-Carnitine, trace elements and water-soluable vitamins 3x / week over 16 weeks + 12 weeks postinterventional observation.
- Control Group (Type: NO_INTERVENTION): Observation over 28 weeks (16 + 12 weeks).

Based on this trial design, predict the completion outcome and termination type (if applicable).